Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2
Open Access
- 22 July 2009
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (29), 9148-9162
- https://doi.org/10.1523/jneurosci.0660-09.2009
Abstract
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominantly inherited, neurodegenerative disease caused by an expansion of polyglutamine tracts in the cytosolic protein ataxin-2 (Atx2). Cerebellar Purkinje cells (PCs) are predominantly affected in SCA2. The cause of PC degeneration in SCA2 is unknown. Here we demonstrate that mutant Atx2–58Q, but not wild-type (WT) Atx2–22Q, specifically associates with the cytosolic C-terminal region of type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), an intracellular calcium (Ca2+) release channel. Association with Atx2–58Q increased the sensitivity of InsP3R1 to activation by InsP3in planar lipid bilayer reconstitution experiments. To validate physiological significance of these findings, we performed a series of experiments with an SCA2–58Q transgenic mouse model that expresses human full-length Atx2–58Q protein under the control of a PC-specific promoter. In Ca2+imaging experiments, we demonstrated that stimulation with 3,5-dihydroxyphenylglycine (DHPG) resulted in higher Ca2+responses in 58Q PC cultures than in WT PC cultures. DHPG-induced Ca2+responses in 58Q PC cultures were blocked by the addition of ryanodine, an inhibitor of the ryanodine receptor (RyanR). We further demonstrated that application of glutamate induced more pronounced cell death in 58Q PC cultures than in WT PC cultures. Glutamate-induced cell death of 58Q PC cultures was attenuated by dantrolene, a clinically relevant RyanR inhibitor and Ca2+stabilizer. In whole animal experiments, we demonstrated that long-term feeding of SCA1–58Q mice with dantrolene alleviated age-dependent motor deficits (quantified in beam-walk and rotarod assays) and reduced PC loss observed in untreated SCA2–58Q mice by 12 months of age (quantified by stereology). Results of our studies indicate that disturbed neuronal Ca2+signaling may play an important role in SCA2 pathology and also suggest that the RyanR constitutes a potential therapeutic target for treatment of SCA2 patients.Keywords
This publication has 76 references indexed in Scilit:
- Neuroprotective Effects of Inositol 1,4,5-Trisphosphate Receptor C-Terminal Fragment in a Huntington's Disease Mouse ModelJournal of Neuroscience, 2009
- Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 3Journal of Neuroscience, 2008
- Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant Ca V 2.1 channelsProceedings of the National Academy of Sciences of the United States of America, 2008
- Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's diseaseNeurobiology of Disease, 2008
- Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's DiseaseJournal of Neuroscience, 2007
- Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell deathExperimental Neurology, 2007
- Generation and characterization of Sca2 (ataxin-2) knockout miceBiochemical and Biophysical Research Communications, 2006
- An Integrative Approach to Gain Insights into the Cellular Function of Human Ataxin-2Journal of Molecular Biology, 2005
- Deranged neuronal calcium signaling and Huntington diseaseBiochemical and Biophysical Research Communications, 2004
- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channelNature Genetics, 1997